%0 Journal Article
%T The Case for Pulmonary Metastasectomy-Clinical Practice Narrative Review and Commentary.
%A Scanagatta P
%A Ancona G
%A Cagnetti S
%A Giorgetta CE
%A Inzirillo F
%A Ravalli E
%A Maiolani M
%A Naldi G
%J Life (Basel)
%V 14
%N 6
%D 2024 May 29
%M 38929685
%F 3.251
%R 10.3390/life14060702
%X Pulmonary metastasectomy has become a well-established procedure for patients with certain types of solid tumors. Patients are usually scheduled for staged lung metastasectomy in case of primary tumor control, the absence of distant non-lung metastases, and when complete resection is achievable. Nodules are removed with precision resection in order to ensure radical resection with minimal margins; this technique permits good oncological results, preserving the surrounding pulmonary parenchyma and causing minimal distortion compared to staplers. When possible, anatomical resections should be avoided since they are not justified by real oncological advantages and, in the majority of cases, sacrifice too much healthy tissue, possibly leading to inoperability in the case of metachronous relapses. Thus, preserving the maximum amount of pulmonary parenchyma is crucial because repeated metastasectomies are possible and frequent, with no theoretical limits to the number of reinterventions. In our multidisciplinary board team, we support the role of pulmonary metastasectomy as a useful curative therapy, with acceptable morbidity and mortality, with indications to be discussed case-by-case.